Barbara Handelin of Audacity Therapeutics is on an important mission to change the way in which funds can be raised for drug development and/or repurposing to meet the needs of the 90 per cent of us who have a condition with no effective treatment. She and her team’s work may likely change an industry. What I am talking about here is a change from focusing on headline-grabbing “blockbusters” engineered by Wall Street/Pharma,  to instead developing products to treat any disease based on ...